Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study


Por: Valldeoriola, F, Regidor, I, Minguez-Castellanos, A, Lezcano, E, Garcia-Ruiz, P, Rojo, A, Salvador, A, Castro, A, Grandas, F, Kulisevsky, J, Marti, MJ, Martinez-Martin, P, Relova, L, Rumia, J, Camara, A, Burguera, JA, Linazasoro, G, de Val, JL, Obeso, J, Rodriguez-Oroz, MC, Tolosa, E

Publicada: 10 ene 2010
Resumen:
Background: Dystonia is a complex clinical syndrome originated by a wide range of aetiologies. The diagnosis of dystonia is made after the evaluation of aetiological, phenomenological and genetic factors.(1) Medications, except in patients with dopa-responsive dystonia, are of limited efficacy. Botulinum toxin injections are not applicable to patients with generalised dystonia, since many muscular groups contribute to disability.(2) Clinical studies in children and adults with primary generalised dystonia (PGD) have reported beneficial effects of bilateral GPi deep brain stimulation (DBS) in both motor symptoms and disability produced by dystonia(3-5) as well as a favourable impact of DBS in the health-related quality of life (HRQoL).(6) Some clinical aspects of GPi stimulation in primary dystonia still remain controversial such as the influence of disease duration or age at onset in determining the postoperative clinical outcome. Results: The authors report the results of a multicentric study designed to assess the tolerability and clinical effects of bilateral pallidal DBS on motor impairment, functional disability, quality of life, pain and mood in patients with medically refractory primary generalised or segmental dystonia.

Filiaciones:
Valldeoriola, F:
 Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain

Regidor, I:
 Hosp Ramon & Cajal, E-28034 Madrid, Spain

Minguez-Castellanos, A:
 Hosp Univ Virgen Nieves, Granada, Spain

Lezcano, E:
 Hosp Cruces, Baracaldo, Spain

Garcia-Ruiz, P:
 Fdn Jimenez Diaz, E-28040 Madrid, Spain

Rojo, A:
 Hosp Mutua Terrassa, Terrassa, Spain

Salvador, A:
 Hosp Clin, Valencia, Spain

Castro, A:
 Univ Hosp, Santiago De Compostela, Spain

Grandas, F:
 Hosp Gen Gregorio Maranon, Madrid, Spain

Kulisevsky, J:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Marti, MJ:
 Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain

Martinez-Martin, P:
 Inst Salud Carlos III, CIBERNED, Inst Nacl Epidemiol, Madrid, Spain

Relova, L:
 Univ Hosp, Santiago De Compostela, Spain

Rumia, J:
 Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain

Camara, A:
 Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain

Burguera, JA:
 Hosp La Fe, E-46009 Valencia, Spain

Linazasoro, G:
 Clin Donosti, San Sebastian, Spain

de Val, JL:
 Hosp Clin, Zaragoza, Spain

Obeso, J:
 Univ Navarra Clin, Madrid, Spain

Rodriguez-Oroz, MC:
 Univ Navarra Clin, Madrid, Spain

Tolosa, E:
 Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain
ISSN: 00223050
Editorial
BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 81 Número: 1
Páginas: 65-69
WOS Id: 000272855400017
ID de PubMed: 19744963
imagen Open Access

MÉTRICAS